Abstract
Within the literature, it appears evident that neither a univariate etiologic model nor a single-agent treatment approach is sufficient to address the many diagnostic, assessment, and therapeutic challenges posed by irritable bowel syndrome (IBS). Various scientific advances have been made over the past 5 years, particularly in the areas of nonpharmacologic management of IBS. However, further collaboration between scientists and clinicians from multiple disciplines is strongly encouraged.
Original language | English |
---|---|
Pages (from-to) | 54-59 |
Number of pages | 6 |
Journal | Current review of pain |
Volume | 4 |
Issue number | 1 |
DOIs | |
State | Published - 2000 |